HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

poly(vinylpyrrolidone-co-dimethyl maleic anhydride)

structure in first source

Also Known As:

poly(VP-co-DMMAn)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrrolidines: 115
    - poly(vinylpyrrolidone-co-dimethyl maleic anhydride): 2
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkenes: 265
      - Vinyl Compounds: 2
        poly(vinylpyrrolidone-co-dimethyl maleic anhydride): 2

Experts

1.	Kamada, Haruhiko: 2 articles (05/2006 - 04/2003)
2.	Nakagawa, Shinsaku: 2 articles (05/2006 - 04/2003)
3.	Tsutsumi, Yasuo: 2 articles (05/2006 - 04/2003)
4.	Abe, Yasuhiro: 1 article (05/2006)
5.	Shibata, Hiroko: 1 article (05/2006)
6.	Tsunoda, Shin-Ichi: 1 article (05/2006)
7.	Mayumi, Tadanori: 1 article (04/2003)
8.	Nagata, Satoshi: 1 article (04/2003)
9.	Okamoto, Takayuki: 1 article (04/2003)
10.	Sato-Kamada, Keiko: 1 article (04/2003)

Related Diseases

1.	Acute Kidney Injury (Acute Renal Failure) 04/01/2003 - "Poly(VP-co-DMMAn)-modified superoxide dismutase accumulated in the kidneys after intravenous administration and accelerated recovery from acute renal failure in a mouse model. "
2.	Neoplasms (Cancer) 05/01/2006 - "Recently, we have synthesized a novel polymeric drug carrier, poly(vinylpyrrolidone-co-dimethyl maleic anhydride) [PVD], which was a powerful candidate drug carrier for cancer therapy. "

Related Drugs and Biologics

1.	Superoxide Dismutase
2.	Drug Carriers

Related Therapies and Procedures

1.	Intravenous Administration
2.	Therapeutics